Related Experiment Video

Updated: May 30, 2026

Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue
04:41

Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue

Published on: July 28, 2023

Keloids: prevention and management

Douglas M Sidle1, Haena Kim

  • 1Division of Facial Plastic Surgery, Department of Otolaryngology-Head and Neck Surgery, Northwestern University Feinberg School of Medicine, 676 North Street Clair, Suite 1325, Chicago, IL 60611, USA. drsidle@yahoo.com

Facial Plastic Surgery Clinics of North America
|August 23, 2011
PubMed

Insights

Keloids stem from disrupted wound healing. Early recognition and treatments like surgery with silicone or triamcinolone are key, though keloid recurrence is possible. Newer chemotherapies show promise.

Area of Science:

  • Dermatology
  • Wound Healing Research
  • Regenerative Medicine

Background:

  • Keloids arise from aberrant wound healing, disrupting tissue regeneration and scar remodeling.
  • Understanding keloid pathogenesis is ongoing, yet various treatment modalities are available.
  • Preventing keloid formation is ideal, but early detection aids treatment and recurrence prevention.

Purpose of the Study:

  • To review current understanding of keloid formation.
  • To discuss established and emerging therapeutic strategies for keloid management.
  • To highlight the importance of early recognition in keloid treatment.

Main Methods:

  • Literature review of keloid pathogenesis and treatment options.
  • Analysis of conventional therapies including surgical resection and adjuvant treatments.
  • Evaluation of novel chemotherapeutic agents for keloid treatment.

Main Results:

  • Surgical resection with silicone gel sheeting or triamcinolone injection are common, but recurrence remains a challenge.
  • Emerging treatments involve chemotherapeutics like 5-fluorouracil, bleomycin, and mitomycin C.
  • Initial findings for these new treatments are encouraging, warranting further investigation.

Conclusions:

  • Keloid management requires a multi-faceted approach, balancing prevention, early detection, and effective treatment.
  • While established treatments exist, their efficacy is limited by potential recurrence.
  • Novel chemotherapeutic agents represent a promising avenue for future keloid treatment, pending further clinical validation.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...